VMI
VHCP Management II Portfolio holdings
AUM
$379M
This Quarter Return
+13.48%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
–
10 Year Return
–
AUM
$317M
AUM Growth
+$317M
(-7.2%)
Cap. Flow
-$19.8M
Cap. Flow
% of AUM
-6.23%
Top 10 Holdings %
Top 10 Hldgs %
86.56%
Holding
22
New
1
Increased
4
Reduced
8
Closed
1
Top Buys
| 1 |
Axsome Therapeutics
AXSM
|
$8.27M |
| 2 |
Milestone Pharmaceuticals
MIST
|
$4.03M |
| 3 |
Protagonist Therapeutics
PTGX
|
$1.88M |
| 4 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$1.36M |
| 5 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$1.34M |
Top Sells
| 1 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$21.1M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$7.67M |
| 3 |
KalVista Pharmaceuticals
KALV
|
$4.35M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$1.42M |
| 5 |
KDMN
Kadmon Holdings, Inc.
KDMN
|
$1.18M |
Sector Composition
| 1 | Healthcare | 98.24% |
